Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Phenotypes of JAK2 -Mutated Polycythemia Vera and Essential Thrombocythemia with and without Thromboembolic Events: Results of the Hinc-207 (OSHO #91) Study

Tony Hennersdorf, Nadja Jaekel, Susann Schulze, MD, Dietrich Kaempfe, MD, Claudia Spohn, MD, Regina Moeller, MD, Maik Schwarz, MD, Hans-Juergen Hurtz, MD, Joern Ruessel, MD, Peter Tornow, Ute Neef, MD, Marion Schmalfeld, MD, Kathleen Jentsch-Ullrich, MD, Thoralf Lange, MD, Christian Junghanss, MD, Brigitte Kragl, MD, Haifa Kathrin Al-Ali, MD

Blood (2020) 136 (Supplement 1): 13.

https://doi.org/10.1182/blood-2020-139366

Published: 2020

Journal Articles

Inflammation Induced Expression of Ybx1 Mediates Resistance to JAK-Kinase Inhibitor Therapy in Myeloproliferative Neoplasia

Carolin Herzog, Anja Polanetzki, Stephanie Frey, Tina M Schnoeder, PhD, Denise Wolleschak, MD, Nomusa Mashamba, MSc, Veera Raghavan Thangapandi, Kathleen Jentsch-Ullrich, MD, Christoph Kahl, MD, Nicolas Schroeder, MD, Peter R Mertens, MD, Thomas Fischer, MD, Florian H Heidel, MD

Blood (2014) 124 (21): 161.

https://doi.org/10.1182/blood.V124.21.161.161

Published: 2014

Journal Articles

CD34+ FISH As a New Method for Molecular-Cytogenetic Diagnostic From Peripheral Blood in MDS: Update of the Multicenter German Prospective Diagnostic Study

Blood (2012) 120 (21): 3816.

https://doi.org/10.1182/blood.V120.21.3816.3816

Published: 2012

Journal Articles

Detection of Karyotype Evolution From Peripheral Blood by Sequential FISH Analyses of Circulating CD34+ Cells In MDS Patients: Results of the Ongoing German Multicenter Prospective Diagnostic Study

Friederike Braulke, MD, Julie Schanz, MD, Michael Metz, MD, Sven Detken, MD, Joerg Seraphin, MD, Katharina Götze, MD, Catharina Mueller-Thomas, MD, Uwe Platzbecker, MD, Tim Henrik Brümmendorf, MD, Aristoteles A.N. Giagounidis, MD, Ulrich Germing, MD, Kathleen Jentsch-Ullrich, MD, Angelika Boehme, MD, Gesine Bug, MD, Oliver G. Ottmann, Prof, Dr., med., Philippe Schafhausen, MD, Lorenz Trümper, MD, Detlef Haase, MD

Blood (2010) 116 (21): 2937.

https://doi.org/10.1182/blood.V116.21.2937.2937

Published: 2010

Journal Articles

High Dose Cytarabine Salvage Regimen Combined with Bortezomib Is Feasible and Highly Effective in Relapsed Mantle Cell Lymphoma.

Oliver Weigert, MD, Eckhart Weidmann, MD, Rudolf Mueck, MD, Martin Bentz, MD, Christoph von Schilling, MD, Robert Rohrberg, MD, Kathleen Jentsch-Ullrich, MD, Michael Unterhalt, MD, Wolfgang Hiddemann, MD, Martin H. Dreyling, MD

Blood (2006) 108 (11): 2449.

https://doi.org/10.1182/blood.V108.11.2449.2449

Published: 2006

Journal Articles

Tumor Burden Related Immunodeficiency in Lymphoma Patients and Clinical Course.

Kathleen Jentsch-Ullrich, MD, Annegret Gerber, MD, Regina Reppin, MD, Michael Koenigsmann, MD, PhD, Martin Mohren, MD, Astrid Franke

Blood (2005) 106 (11): 4649.

https://doi.org/10.1182/blood.V106.11.4649.4649

Published: 2005

Journal Articles

Increased Risk for Venous Thromboembolism in Patients with Acute Leukemia.

Martin Mohren, MD, Ilka Markmann, Kathleen Jentsch-Ullrich, MD, Michael Koenigsmann, MD, Gerd Lutze, MD, Astrid Franke, MD

Blood (2005) 106 (11): 4555.

https://doi.org/10.1182/blood.V106.11.4555.4555

Published: 2005

Journal Articles

Increased Risk for Thromboembolism Associated with High Coagulation Factor VIII (F VIII) Levels in Patients with Malignant Lymphoma.

Martin Mohren, MD, Ilka Markmann, Astrid Franke, MD, Kathleen Jentsch-Ullrich, MD, Michael Koenigsmann, MD, Gerd Lutze, MD

Blood (2004) 104 (11): 1380.

https://doi.org/10.1182/blood.V104.11.1380.1380

Published: 2004

Journal Articles

Improved Outcome in Adult T-ALL by Risk Adapted Treatment Strategies.

Nicola Goekbuget, MD, Eckhard Thiel, MD, Joachim Beck, MD, Frank Griesinger, MD, Frank Hartmann, MD, Kathleen Jentsch-Ullrich, MD, Sabine Knipp, MD, Thomas Lipp, MD, Dorle Messerer, Bernd Metzner, MD, Jan Rutjes, MD, Mathias Schmid, MD, Stefan Schwartz, MD, Peter Staib, MD, Matthias Stelljes, MD, Dieter Hoelzer, MD

Blood (2004) 104 (11): 682.

https://doi.org/10.1182/blood.V104.11.682.682

Published: 2004

Journal Articles

Cellular Immunodeficiency in Untreated Lymphoma Patients.

Kathleen Jentsch-Ullrich, MD, Annegret Gerber, MD, Regina Reppin, MD, Michael Koenigsmann, MD, Martin Mohren, MD, Astrid Franke, MD

Blood (2004) 104 (11): 4555.

https://doi.org/10.1182/blood.V104.11.4555.4555

Published: 2004

NARROW

Phenotypes of JAK2 -Mutated Polycythemia Vera and Essential Thrombocythemia with and without Thromboembolic Events: Results of the Hinc-207 (OSHO #91) Study

Inflammation Induced Expression of Ybx1 Mediates Resistance to JAK-Kinase Inhibitor Therapy in Myeloproliferative Neoplasia

CD34+ FISH As a New Method for Molecular-Cytogenetic Diagnostic From Peripheral Blood in MDS: Update of the Multicenter German Prospective Diagnostic Study

Detection of Karyotype Evolution From Peripheral Blood by Sequential FISH Analyses of Circulating CD34+ Cells In MDS Patients: Results of the Ongoing German Multicenter Prospective Diagnostic Study

High Dose Cytarabine Salvage Regimen Combined with Bortezomib Is Feasible and Highly Effective in Relapsed Mantle Cell Lymphoma.

Tumor Burden Related Immunodeficiency in Lymphoma Patients and Clinical Course.

Increased Risk for Venous Thromboembolism in Patients with Acute Leukemia.

Increased Risk for Thromboembolism Associated with High Coagulation Factor VIII (F VIII) Levels in Patients with Malignant Lymphoma.

Improved Outcome in Adult T-ALL by Risk Adapted Treatment Strategies.

Cellular Immunodeficiency in Untreated Lymphoma Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only